A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan
NCT06741683
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
187
Enrollment
INDUSTRY
Sponsor class
Conditions
Dengue Fever
Interventions
BIOLOGICAL:
TDV
OTHER:
Placebo
Sponsor
Takeda